The Committee for Orphan Medicinal Products (COMP) is one of the EMA’s scientific committees. It is responsible for assessing applications for “Orphan Drug Status”, which should promote the development of medicinal products for rare diseases.

Organiser: Federal Ministry of Health

Continue reading


Bundesinstitut für Arzneimittel und Medizinprodukte

Fachgebiet Internationaler Austausch und Konferenzen

+49 228 99307 3183